| Date | Time | Source | Headline | Symbol | Company |
| 02/08/2007 | 10:00AM | PR Newswire (US) | Avalon Pharmaceuticals to Present at BIO CEO & Investor Conference 2007 | NASDAQ:AVRX | |
| 01/23/2007 | 3:32PM | PR Newswire (US) | Avalon Pharmaceuticals Closes $10 Million in Private Placement of Common Stock to Institutional Investors | NASDAQ:AVRX | |
| 01/22/2007 | 6:30AM | PR Newswire (US) | Avalon Pharmaceuticals Raises $10 Million in Private Placement of Common Stock to Institutional Investors | NASDAQ:AVRX | |
| 01/04/2007 | 6:30AM | PR Newswire (US) | Avalon Pharmaceuticals Names Clinical Advisory Board | NASDAQ:AVRX | |
| 12/13/2006 | 4:55PM | PR Newswire (US) | Avalon Pharmaceuticals Announces Positive Interim Results for AVN944 Phase I Trial | NASDAQ:AVRX | |
| 12/11/2006 | 6:30AM | PR Newswire (US) | Avalon's AVN944 Inhibits IMPDH and Induces Apoptosis-Related Biomarkers in Patients With Hematological Cancers | NASDAQ:AVRX | |
| 12/08/2006 | 7:00AM | PR Newswire (US) | Avalon to Host Conference Call on AVN944 Phase I Interim Results on December 14, 2006 at 8 a.m. EST | NASDAQ:AVRX | |
| 12/04/2006 | 6:30AM | PR Newswire (US) | Avalon Pharmaceuticals to Present at the American Society of Hematology 2006 Annual Meeting | NASDAQ:AVRX | |
| 11/07/2006 | 4:01PM | PR Newswire (US) | Avalon Pharmaceuticals Reports Third Quarter 2006 Results | NASDAQ:AVRX | |
| 11/07/2006 | 6:00AM | PR Newswire (US) | Avalon Pharmaceuticals Initiate Drug Discovery Program for the Survivin Pathway | NASDAQ:AVRX | |
| 11/06/2006 | 9:47AM | PR Newswire (US) | Avalon Pharmaceuticals to Present at Rodman and Renshaw 8th Annual Healthcare Conference | NASDAQ:AVRX | Avalon Pharmaceuticals (MM) |
| 11/06/2006 | 9:47AM | PR Newswire (US) | Avalon Pharmaceuticals to Present at Rodman and Renshaw 8th Annual Healthcare Conference | NASDAQ:AVRX | |
| 11/01/2006 | 6:30AM | PR Newswire (US) | Avalon Pharmaceuticals Names Todd R. Golub, M.D. as Chairman and Member of Its Scientific Advisory Board | NASDAQ:AVRX | |
| 11/01/2006 | 6:00AM | PR Newswire (US) | Avalon to Release Third Quarter 2006 Financial Results on November 7th, 2006 | NASDAQ:AVRX | Avalon Pharmaceuticals (MM) |
| 10/30/2006 | 6:30AM | PR Newswire (US) | Avalon Pharmaceuticals to Present at Susquehanna Financial Group Emerging Trends Conference 2006 | NASDAQ:AVRX | Avalon Pharmaceuticals (MM) |
| 10/16/2006 | 7:00AM | PR Newswire (US) | Avalon Pharmaceuticals to Present at BIO InvestorForum 2006 | NASDAQ:AVRX | |
| 10/13/2006 | 7:00AM | PR Newswire (US) | Avalon Pharmaceuticals Appoints David Kabakoff, Ph.D., to Its Board of Directors | NASDAQ:AVRX | |
| 09/27/2006 | 7:00AM | PR Newswire (US) | Avalon Pharmaceuticals Appoints David D. Muth to Executive Vice President, Chief Business Officer | NASDAQ:AVRX | |
| 08/08/2006 | 5:30PM | PR Newswire (US) | Avalon Pharmaceuticals Reports Second Quarter 2006 Results | NASDAQ:AVRX | |
| 08/01/2006 | 7:30AM | PR Newswire (US) | Avalon Pharmaceuticals Appoints J. Michael Hamilton, M.D., Chief Medical Officer | NASDAQ:AVRX | |
| 07/31/2006 | 11:00AM | PR Newswire (US) | Avalon to Release Second Quarter 2006 Financial Results on August 8, 2006 | NASDAQ:AVRX | |
| 07/26/2006 | 7:30AM | PR Newswire (US) | Avalon and ChemDiv to Collaborate in Oncology Drug Discovery and Development | NASDAQ:AVRX | |
| 05/16/2006 | 1:00PM | PR Newswire (US) | BIO IT Coalition Awards Avalon Pharmaceuticals 2006 Best Practices Company Award | NASDAQ:AVRX | |
| 05/15/2006 | 2:15PM | PR Newswire (US) | Avalon Pharmaceuticals to Present at Bank of America Annual Health Care Conference 2006 | NASDAQ:AVRX | |
| 05/10/2006 | 5:30PM | PR Newswire (US) | Avalon Pharmaceuticals Reports First Quarter 2006 Results | NASDAQ:AVRX | |
| 05/04/2006 | 11:00AM | PR Newswire (US) | Avalon Pharmaceuticals to Present at Rodman & Renshaw 3rd Annual Global Healthcare Conference | NASDAQ:AVRX | |
| 05/02/2006 | 1:35PM | PR Newswire (US) | Avalon to Release First Quarter 2006 Financial Results on May 10, 2006 | NASDAQ:AVRX | |
| 03/30/2006 | 1:25PM | PR Newswire (US) | Avalon Pharmaceuticals to Present Data on AVN944 and Pre-Clinical Programs at AACR | NASDAQ:AVRX | |
| 03/23/2006 | 9:00AM | PR Newswire (US) | Avalon Pharmaceuticals to Ring the NASDAQ Closing Bell on March 27, 2006 | NASDAQ:AVRX | |
| 03/07/2006 | 4:30PM | PR Newswire (US) | Avalon Pharmaceuticals Reports Fourth Quarter and Full Year 2005 Results | NASDAQ:AVRX | |